Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122226492 | 12222649 | 2 | F | 2015 | 20160107 | 20160330 | 20160729 | EXP | US-MYLANLABS-2016M1001572 | MYLAN | 0.00 | Y | 0.00000 | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122226492 | 12222649 | 1 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 100 ?G, QH, CHANGED Q72H | 615059 | 76258 | 100 | UG | TRANSDERMAL PATCH | /hr | |||||
| 122226492 | 12222649 | 2 | C | DILANTIN | PHENYTOIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122226492 | 12222649 | 1 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122226492 | 12222649 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122226492 | 12222649 | Application site irritation | |
| 122226492 | 12222649 | Arrhythmia | |
| 122226492 | 12222649 | Drug effect decreased | |
| 122226492 | 12222649 | Heart rate increased | |
| 122226492 | 12222649 | Hyperhidrosis | |
| 122226492 | 12222649 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122226492 | 12222649 | 1 | 2015 | 0 |